Dr. Sanjeeva Srivastavasanjeeva
Associate Professor
Convener, Targeted Proteomics Workshop & International Symposium
Department of Biosciences and Bioengineering
Room #304, Proteomics Laboratory
Indian Institute of Technology Bombay
Powai, Mumbai 400 076, India
Phone: + (91-22) 2576-7779
URL: Lab -

I have considerable experience for teaching proteomics courses and conducting hands-on crash-courses on proteomics at IIT Bombay and many other institutes including proteomics workshop at Reliance Life Sciences, Mumbai, Continuing Education Programme (CEP) on proteomics at IIT Bombay, and three proteomics courses in Cold Spring Harbor Laboratory (CSHL), New York. Apart from the regular research work, we have been actively involved in the development of various proteomics e-Learning & Open-Learning curriculums and Virtual Lab initiatives at IIT Bombay generated with an intention to disseminate high-quality educational materials on proteomics at a global scale [Ray et al., PLoS Biol. 2012; Ray et al., J Proteomics. 2012; Srivastava et al., Nature 2013]. These Virtual Lab initiatives have been included as a part (Tutorial- IPTP 14) of the International Proteomics Tutorial Programme (supported by Human Proteome Organization (HUPO) and European Proteomics Association (EuPA)).

At IIT Bombay we have established an excellent infrastructure for quantitative and targeted proteomics and metabolomics at IIT Bombay, which includes different instrumentations and software for gel-based proteomics [Two Dimensional gel Electrophoresis (2-DE) and 2D- Differential Gel Electrophoresis (2D-DIGE) [Ettan IPGphore 3 isoelectric focusing unit (GE Healthcare), Ettan DALT six electrophoresis unit (GE Healthcare), LabScan software version 6.0 (GE Healthcare), Image Master 2D Platinum 7.0 software (GE Healthcare), ImageQuant software version 5.0 (GE Healthcare), Typhoon 9400 variable mode imager (GE Healthcare) and DeCyder 2D software, version 7.0 (GE Healthcare)], and MS-based proteomics and metabolomics platforms [MALDI TOF/TOF MS (4800 MALDI-TOF/TOF mass spectrometer (AB Sciex, Framingham, MA), Autoflex Speed (Bruker Daltonics)), 3100 OFFGEL fractionator (Agilent Technologies, Santa Clara, CA), Agilent 6550 iFunnel Q-TOF LC MS/MS instrument (Agilent Technologies, USA), Accu TOF GCv (JMS-T100GCv) system from Jeol Asia equipped with Agilent 7690 GC, Spectrum Mill Protein Identification software (Agilent Technologies, USA), MASCOT version 2.1 (, Mass Profiler Professional (MPP) software package (version 2.2, Agilent Technologies, Santa Clara, CA, USA) and Surface Plasmon Resonance (SPR): Biacore T200 system (GE Healthcare), Gene Pix Pro Microarray Scanner; Microarrayer printer]. Consequently, we have both expertise and infrastructure for conducting such bilateral training program at IIT Bombay.

Professional Experience:

  • Associate Professor – Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, India)
  • Assistant Professor – Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, India) 2009 – July 2014
  • Postdoctoral fellow – Harvard Institute of Proteomics – Harvard Medical School, USA (2007-2009)
  • Deputy Editor-in-Chief – Current Pharmacogenomics and Personalized Medicine (Amsterdam, Netherlands; 2012 – present); Scopus Impact Factor: 1.76
  • Associate Editor – OMICS: A Journal of Integrative Biology (New York, USA; 2013 – present); SCI Impact Factor: 2.74; Indexed in Science Citation Index, MEDLINE
  • Associate Editor – Journal of Integrated OMICS (2011 – present)
  • Co-Founder and Member, Board of Directors – Data-Enabled Life Sciences Alliance International (DELSA Global, Seattle, USA)
  • Founder – Data-Enabled Life Sciences Alliance (DELSA) India (2013)
  • Professor of Clinical Pharmacology – Honorary Academic Appointment, Central South University, Changsha, Hunan, China (5/2012 – 2017)
  • Visiting Scientist – Biodesign Institute, Arizona State University

Selected Recent Publications:

  • Moiyadi, A., et al. Fluorescence-guided surgery of malignant gliomas based on 5-aminolevulinic acid: paradigm shifts but not a panacea. Nat. Rev. Cancer 14, 146 (2014).
  • Gupta, S. et al.. Challenges and prospects for biomarker research: A current perspective from the developing world. Biochim. Biophys. Acta (2014). doi:10.1016/j.bbapap.2013.12.020
  • Ray, S., et al. Epidemiology: Biorepositories for cancer research in developing countries. Nat. Rev. Clin. Oncol. 10, 434–436 (2013).
  • Srivastava, S. et al. Online education: E-learning booster in developing world. Nature 501, 316 (2013).
  • Kolker, E. et al. Reproducibility: In praise of open research measures. Nature 498, 170 (2013).
  • Ray, S., et al. Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures. Proteomics Clin. Appl. 8, 53–72 (2014).
  • Ray, S. et al. Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. Plos One 7, e41751 (2012).
  • Ray, S. et al. Sakshat Labs: India’s virtual proteomics initiative. Plos Biol. 10, e1001353 (2012).
  • Gollapalli, K. et al. Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics 12, 2378–2390 (2012).
  • Srivastava, S. & LaBaer, J. Nanotubes light up protein arrays. Nat. Biotechnol. 26, 1244–1246 (2008).

Recent Invited Lectures:

  • World Human Proteome Organization, Yokohama, Japan, Sep 15, 2013.
  • US-Human Proteome Organization, Baltimore, USA, March 8, 2013.
  • Central South University Changsha China, May 30, 2012.
  • Monash University, Australia, March 2012.
  • Faculty Association Network IIT Bombay, Santa Clara, California, USA, Sep 2010.
  • Conway Institute, University College Dublin, Ireland, May 2010.
  • Johns Hopkins University School of Medicine, USA, March 2010.